MinichMacGregor Wealth Management’s Gilead Sciences GILD Stock Holding History

MinichMacGregor Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,008	Closed	-$280K	–	156
2026 Q1	$280K	Buy	+2,008	New	+$281K	0.05%	102
2023 Q1	–	Sell	-588	Closed	-$50.5K	–	301
2022 Q4	$50.5K	Buy	+588	New	+$46.6K	0.02%	178
2018 Q4	–	Sell	-125	Closed	-$9K	–	243
2018 Q3	$9K	Hold	125	–	–	0.01%	324
2018 Q2	$8K	Sell	125 -233	-65%	-$16.5K	0.01%	333
2018 Q1	$26K	Buy	358 +31	+9%	+$2.46K	0.02%	177
2017 Q4	$23K	Hold	327	–	–	0.02%	187
2017 Q3	$26K	Hold	327	–	–	0.02%	164
2017 Q2	$23K	Hold	327	–	–	0.02%	173
2017 Q1	$22K	Sell	327 -181	-36%	-$12.7K	0.02%	172
2016 Q4	$36K	Sell	508 -199	-28%	-$14.8K	0.03%	128
2016 Q3	$55K	Buy	707 +1	+0.1%	+$81	0.05%	109
2016 Q2	$58K	Sell	706 -101	-13%	-$8.96K	0.05%	96
2016 Q1	$74K	Sell	807 -182	-18%	-$16.4K	0.07%	82
2015 Q4	$111K	Buy	+989	New	+$103K	0.1%	54

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

MinichMacGregor Wealth Management's GILD Position: Q2 2026 in Review

MinichMacGregor Wealth Management sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 2,008 shares — an estimated $280K sold.

MinichMacGregor Wealth Management first reported a position in GILD in Q4 2015 and held it in 14 quarters. The position peaked at $280K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

MinichMacGregor Wealth Management reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
MinichMacGregor Wealth Management sold 2,008 Gilead Sciences shares in Q2 2026, an estimated $280K.
MinichMacGregor Wealth Management first reported a position in Gilead Sciences in Q4 2015 and held it in 14 quarters.
MinichMacGregor Wealth Management's Gilead Sciences position peaked at $280K in Q1 2026.
2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on MinichMacGregor Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.